GlassScriptPhysician profile
Hillary V Tudor
NPI 1306096425
$1,036.98
in general payments reported to CMS, 2019-2025
22 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $7.23 · 2021: $50.18 · 2022: $146 · 2023: $117 · 2024: $30.68 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $197.94 | 2025 | Purified Cortrophin Gel |
| Biocomposites INC | $147.90 | 2025 | Stimulan |
| Angiodynamics, INC. | $113.06 | 2022 | |
| Paratek Pharmaceuticals, INC. | $78.75 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $58.26 | 2019-2025 | Renasys Go V2 Home |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $50.30 | 2022-2023 | Jublia |
| Amgen INC. | $49.11 | 2025 | Krystexxa |
| Bioventus LLC | $40.12 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $40.01 | 2025 | Flexitouch Plus, Nimbl |
| Nabriva Therapeutics, Plc | $35.85 | 2021-2022 | |
| Inari Medical, INC. | $34.60 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Orthofix Medical, INC. | $27.36 | 2019-2025 | Physio-Stim |
| Melinta Therapeutics, LLC | $24.16 | 2019 | |
| Averitas Pharma INC. | $23.99 | 2025 | Qutenza |
| Stryker Corporation | $21.80 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $19.86 | 2023 | Senza |
| Medtronic, INC. | $14.85 | 2025 | Inceptiv |
| Merck Sharp & Dohme LLC | $13.58 | 2019 | |
| Paragon 28, INC. | $13.10 | 2023 | |
| Horizon Therapeutics Plc | $12.82 | 2023 | Krystexxa |
| Pfizer INC. | $12.41 | 2019 | |
| Cashflow Solutions, LLC | $7.15 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Tudor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.